Morgan Stanley’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13
| Closed | -$81 | – | 8179 |
|
|
2024
Q4 | $81 | Sell |
13
-62
| -83% | -$386 | ﹤0.01% | 7500 |
|
|
2024
Q3 | $526 | Buy |
75
+69
| +1,150% | +$484 | ﹤0.01% | 7296 |
|
|
2024
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 7154 |
|
|
2024
Q1 | – | Hold |
0
| – | -$1.41K | – | 7312 |
|
|
2023
Q4 | – | Hold |
0
| – | -$867 | – | 7173 |
|
|
2023
Q3 | – | Hold |
0
| – | -$1.09K | – | 7253 |
|
|
2023
Q2 | – | Sell |
-15
| Closed | -$58.9K | – | 7282 |
|
|
2023
Q1 | $58.9K | Sell |
15
-10
| -40% | -$39.3K | ﹤0.01% | 6217 |
|
|
2022
Q4 | $176K | Hold |
25
| – | – | ﹤0.01% | 5720 |
|
|
2022
Q3 | $265K | Buy |
25
+1
| +4% | +$10.6K | ﹤0.01% | 5587 |
|
|
2022
Q2 | $199K | Hold |
24
| – | – | ﹤0.01% | 5898 |
|
|
2022
Q1 | $332K | Hold |
24
| – | – | ﹤0.01% | 5626 |
|
|
2021
Q4 | $583K | Buy |
24
+17
| +243% | +$413K | ﹤0.01% | 5452 |
|
|
2021
Q3 | $402K | Hold |
7
| – | – | ﹤0.01% | 5628 |
|
|
2021
Q2 | $506K | Buy |
7
+1
| +17% | +$72.3K | ﹤0.01% | 5517 |
|
|
2021
Q1 | $573K | Buy |
+6
| New | +$573K | ﹤0.01% | 5077 |
|
|
2020
Q4 | – | Hold |
0
| – | -$11K | – | 6741 |
|
|
2020
Q3 | – | Hold |
0
| – | -$2K | – | 6246 |
|
|
2020
Q2 | – | Hold |
0
| – | -$1K | – | 6457 |
|
|
2020
Q1 | – | Hold |
0
| – | -$4K | – | 6474 |
|
|
2019
Q4 | – | Hold |
0
| – | -$2K | – | 6431 |
|
|
2019
Q3 | – | Hold |
0
| – | -$5K | – | 6482 |
|
|
2019
Q2 | – | Hold |
0
| – | -$3K | – | 6313 |
|
|
2019
Q1 | – | Hold |
0
| – | -$2K | – | 6401 |
|
|
2018
Q4 | – | Hold |
0
| – | -$5K | – | 6422 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6447 |
|